Updated Jul 16, 2026
Ling Karen has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — buying. Lifetime open-market purchases: $71K.
Karen Ling is a corporate executive currently serving as a Director at Bausch + Lomb Corp, a global eye health company. She has been involved in various leadership roles in the healthcare and pharmaceutical sectors.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-29 | IRTC | iRhythm Holdings, Inc. | A — Grant or award | 1.6K | $0.00 | |
| 2026-05-28 | BLCO | Bausch & Lomb Corp | A — Grant or award | 15.8K | $15.78 | $250K |
| 2026-02-23 | BLCO | Bausch & Lomb Corp | A — Grant or award | 4.0K | $0.00 | |
| 2026-02-23 | BLCO | Bausch & Lomb Corp | P — Open-market purchase | 4.0K | $17.74 | $71K |
Karen Ling is a corporate executive currently serving as a Director at Bausch + Lomb Corp, a global eye health company. She has been involved in various leadership roles in the healthcare and pharmaceutical sectors.…
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 1 open-market purchases ($71K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Ling Karen profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.